COVID-19 Show message

Skip to content

Science News About Treatments

NIMH’s Carlos Zarate Jr., M.D., Elected to National Academy of Medicine

Institute Update

Carlos Zarate Jr., M.D., chief of the Experimental Therapeutics and Pathophysiology Branch within the NIMH Intramural Research Program, has been elected to the National Academy of Medicine.

Read More

Neural Signature Identifies People Likely to Respond to Antidepressant Medication

Press Release

NIH-funded research uses machine learning algorithm to predict individual response to a commonly-prescribed antidepressant.

Read More

Side Effects Mild, Brief with Single Antidepressant Dose of Intravenous Ketamine

Press Release

A single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

Read More

NIH Announces Funding Awards for National Early Psychosis Learning Community

Press Release

NIMH awarded six research grants for studies to develop a learning health care system for the treatment of early psychosis.

Read More

Bench-to-Bedside: NIMH Research Leading to Brexanolone, First-Ever Drug Specifically for Postpartum Depression

Media Advisory

FDA approval of the postpartum depression treatment brexanolone represents the final phase of a bench-to-bedside journey for this drug — a journey that began in the NIMH Intramural Research Program. NIMH experts are available to provide information on postpartum depression and the importance of, and the science underlying, this new drug.

Read More

Dynamic Associations Among Motor Activity, Sleep, Energy, and Mood Could Suggest New Focus for Depression Treatment

Science Update

A new study looking at interactions among sleep, energy, activity level, and mood suggests that instability in activity and sleep systems could lead to mood changes. The findings suggest new targets for depression treatment.

Read More

Studies Support Use of Team-Based Care for Early Psychosis

Science Update

Two recent studies add to the evidence that team-based early intervention services are feasible in real-world health care settings and result in improved outcomes for patients.

Read More

Team-based Care Optimizes Medication Treatment for First Episode Psychosis

Science Update

Findings from NIMH’s Recovery After an Initial Schizophrenia Episode (RAISE) project indicate that team-based coordinated specialty care (CSC) for first episode psychosis (FEP) results in more optimal prescribing of antipsychotics and fewer side effects when compared with typical community care.

Read More

A Shorter—but Effective—Treatment for PTSD

Science Update

Research supported by the National Institute of Mental Health has shown that a shorter therapy (written exposure therapy) may be just as effective as lengthier first-line treatments for PTSD.

Read More

Therapy Reduces Risk in Suicidal Youth

Science Update

A recent clinical trial of a psychotherapy called dialectical behavior therapy (DBT)—which has been shown to be effective in reducing suicide-related behavior in adults—showed that DBT can also reduce suicide attempts and suicidal behavior in adolescents.

Read More

Delay in HIV Treatment Associated with Brain Atrophy

Science Update

People infected with the human immunodeficiency virus, known as HIV, display reductions in brain volume compared with people who are not infected with HIV, but now an NIMH-funded study has shed light on the course of this deterioration and shows that antiretroviral treatment started in the first few years of infection may stop these brain changes.

Read More

Molecular Secrets Revealed: Antipsychotic Docked in its Receptor

Press Release

Scientists have deciphered the molecular structure of a widely-prescribed antipsychotic docked in its key human brain receptor. The discovery may hold clues to designing better treatments for schizophrenia, bipolar disorder and other mental illnesses.

Read More

Guidelines published for treating PANS/PANDAS

Science Update

An expert panel has published guidelines for treatment of Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) and a subset of patients diagnosed with PAN Disorder Associated with Streptococcal Infection (PANDAS).

Read More

Imaging Pinpoints Brain Circuits Changed by PTSD Therapy

Science Update

Using brain imaging to track the effects of treatment of post-traumatic stress disorder (PTSD), scientists have identified a brain circuit on which a frequently used and effective psychotherapy (prolonged exposure) acts to quell symptoms. The findings help explain why the neural circuit identified is a promising target for additional treatment development, including brain stimulation therapies.

Read More

Pediatrics-based Brief Therapy Outdoes Referral for Youths with Anxiety and Depression

Science Update

A streamlined behavioral therapy delivered in a pediatrics practice offered much greater benefit to youth with anxiety and depression than a more standard referral to mental health care with follow-up in a clinical trial comparing the two approaches.

Read More

NIMH to Host Multimodal Brain Stimulation Speaker Series

Science Update

Beginning May 31, 2017, the National Institute of Mental Health (NIMH) will launch a speaker series intended to bring together leaders in the field conducting research using non-invasive brain stimulation and functional imaging including EEG, fMRI, and transcranial magnetic stimulation (TMS).

Read More

Brain “Relay” Also Key to Holding Thoughts in Mind

Press Release

Long overlooked as a mere “relay,” an egg-like structure in the middle of the brain also turns out to play a pivotal role in tuning-up thinking circuity. A trio of studies in mice are revealing that the thalamus sustains the ability to distinguish categories and hold thoughts in mind. It might even become a target for interventions for psychiatric disorders marked by working memory problems, such as schizophrenia.

Read More

Prescribing Patterns Change Following Direct Marketing Restrictions

Press Release

A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing found that physicians in academic medical centers (AMCs) prescribed fewer of the promoted drugs, and more non-promoted drugs in the same drug classes, following policy changes to restrict marketing activities at those medical centers.

Read More

Revealed: LSD Docked in its Human Brain Target

Science Update

Scientists have discovered the molecular structure of LSD in its human brain receptor.

Read More

Sex Hormone–Sensitive Gene Complex Linked to Premenstrual Mood Disorder

Press Release

Researchers have discovered molecular mechanisms that may underlie a woman’s susceptibility to disabling irritability, sadness, and anxiety in the days leading up to her menstrual period.

Read More